The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
Romania's GDP fell by 0.2% in Q1 2026 compared to the previous quarter, according to data released by the National Institute of Statistics (INS).
Romania's annual inflation rate reached 10.7% in April 2026 compared to April 2025, according to data released by the National Institute of Statistics (INS).
Agroland Business System has received approval from Romania's Commission for the Examination of Foreign Direct Investments (CEFDI) for a €20 million greenfield investment in egg production. The new facility will be located in Mihăilești, Giurgiu County.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.
Penny Romania ended 2025 with revenue of RON 10.6 billion lei (€2.1 billion), marking a 12.01% increase compared to the previous year. The discount retailer opened 40 new stores, reaching 456 units nationwide, and completed its fifth logistics centre in Mihăilești, Giurgiu County.